Cholesterol reduction impairs exocytosis of synaptic vesicles.
about
The dynamic architecture of photoreceptor ribbon synapses: cytoskeletal, extracellular matrix, and intramembrane proteinsMiglustat Reverts the Impairment of Synaptic Plasticity in a Mouse Model of NPC DiseaseThe role of cholesterol in membrane fusionHigh cholesterol obviates a prolonged hemifusion intermediate in fast SNARE-mediated membrane fusionMultiphasic effects of cholesterol on influenza fusion kinetics reflect multiple mechanistic roles.Long-term atorvastatin treatment leads to alterations in behavior, cognition, and hippocampal biochemistry.Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrinCholesterol in brain disease: sometimes determinant and frequently implicated.Lateral mobility of presynaptic L-type calcium channels at photoreceptor ribbon synapsesMembrane cholesterol removal changes mechanical properties of cells and induces secretion of a specific pool of lysosomes.LTP-triggered cholesterol redistribution activates Cdc42 and drives AMPA receptor synaptic deliveryCholesterol metabolism and homeostasis in the brainCholesterol regulates multiple forms of vesicle endocytosis at a mammalian central synapse.Regulation of presynaptic strength by controlling Ca2+ channel mobility: effects of cholesterol depletion on release at the cone ribbon synapseEnergetics of stalk intermediates in membrane fusion are controlled by lipid composition.Effect of cholesterol reduction on receptor signaling in neurons.The regulated expression, intracellular trafficking, and membrane recycling of the P2Y-like receptor GPR17 in Oli-neu oligodendroglial cells.Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol.Cholesterol Increases the Openness of SNARE-Mediated Flickering Fusion PoresThe lipid composition and physical properties of the yeast vacuole affect the hemifusion-fusion transition.Corpus callosum measurements correlate with developmental delay in Smith-Lemli-Opitz syndrome.Oxysterol-binding protein (OSBP) is required for the perinuclear localization of intra-Golgi v-SNAREs.The E1015K variant in the synprint region of the CaV2.1 channel alters channel function and is associated with different migraine phenotypes.SNAP23-Dependent Surface Translocation of Leukotriene B4 (LTB4) Receptor 1 Is Essential for NOX2-Mediated Exocytotic Degranulation in Human Mast Cells Induced by Trichomonas vaginalis-Secreted LTB4.Splice isoform and pharmacological studies reveal that sterol depletion relocalizes α-synuclein and enhances its toxicityLipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders.Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism.The relationship between statins and depression: a review of the literature.Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.Lipid metabolism in Alzheimer's diseaseRole of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.Cholesterol regulates polymodal sensory transduction in Müller glia.Cellular Cholesterol Facilitates the Postentry Replication Cycle of Herpes Simplex Virus 1.Lovastatin Differentially Affects Neuronal Cholesterol and Amyloid-β Production in vivo and in vitro.Cholesterol and F-actin are required for clustering of recycling synaptic vesicle proteins in the presynaptic plasma membrane.Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol.SNX27, a protein involved in down syndrome, regulates GPR17 trafficking and oligodendrocyte differentiation.Hypothesis: the role of sterols in autism spectrum disorder.Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice.
P2860
Q26865168-068A7DCE-D7AD-4EFF-9CC9-470BABDBD349Q27313634-42570A49-758C-4430-BD6C-00EA31873F76Q30276808-2CD2F986-E054-4ED4-B89C-591B6E759458Q30278968-C60FDE89-EB12-41CA-A7D1-935D86B5C19BQ30410686-9F6A3C83-4F6B-48FD-BB1B-2D911F8C0B42Q33761463-92814260-A7C0-48BE-B42C-FC13DB82F111Q33945068-A6C8C8FA-89B1-4E28-BCD4-5A9B01F8CCCCQ34621446-ED8C329B-BFAC-469C-8DCD-83E7DAE6282CQ35025709-A516D5A3-CA02-420B-A8B4-FCE2F78F0B09Q35077854-8A35C698-F502-402B-85B8-318E2D43A8D0Q35184462-4CC87339-3000-40B1-A4CA-80E7B9D45D91Q35252263-60F830F2-5218-4BA2-9ACD-79DCFE7F88A2Q35815753-2F9CE1D9-1558-4ACF-A01A-5C27BE14DE68Q36043162-3017C2D1-CE5E-4A4A-A944-F463B8CF884CQ36056533-9DEBCFD0-34A3-48AB-86A3-F9F4004797EFQ36283630-312CA694-580E-45C8-8E59-4C7C9A9A24C9Q36620923-187E86E1-D2D4-43E9-8486-5C5B94E58CAFQ36778207-0E9CC33E-AD91-4A47-8674-57C23085D95CQ36804160-7C173B02-9571-412A-BA4F-AAB033240AAEQ36864226-1EF19992-6ADC-4901-916A-B7EB767F6BA7Q37032781-92D24D85-4662-4B77-98C9-231AC66A787BQ37306202-4468A36B-69D8-461C-841A-AD43BF3897B8Q37333758-2FE9DE54-5A2C-48F7-BD34-A0A686E79DF8Q37546918-587AD1C3-2CF7-40F3-A779-0FBABFDB7DF6Q37612718-0ECA6A08-2689-425D-8351-D0D5B7EE59D0Q37681389-9B8E9B66-AFB6-4F82-A459-50AE9722F8ABQ37736008-80780C44-B611-48C6-A632-8CC42282E62FQ38114474-48AC0CCB-E9E9-426E-B072-790F15C54793Q38179262-D08B0FF3-A69A-4AC0-A68A-C664062AD71BQ38204719-BAC92452-4D16-4DA3-A616-90C0D51C05FEQ38414035-98E8784C-D415-4AB7-82E8-30FA938FFFE5Q38574561-BAE8E06F-4D7B-4F0E-94FF-B586BFF193ECQ38600889-18A569DD-5949-4C00-8E47-9352C34D0E15Q38705919-B8DED76E-A357-4593-9CB7-61359A448310Q38861519-8DE784FE-E608-4677-B480-90621C6329ECQ39216305-BFF53771-46E4-45F7-9BC3-C18143FF0CFBQ39478056-57C13567-4F91-466E-9282-7F5BFEAEEF7AQ39704371-C8A467B6-FCA6-4E75-B307-5E51C3B6DDC7Q39799713-415BBEF1-275C-428F-B7E9-C1FB8ED5A8D3Q40295370-BB21761E-269C-4428-B53D-4E81CF61CDEA
P2860
Cholesterol reduction impairs exocytosis of synaptic vesicles.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@ast
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@en
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@nl
type
label
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@ast
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@en
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@nl
prefLabel
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@ast
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@en
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@nl
P2093
P50
P356
P1476
Cholesterol reduction impairs exocytosis of synaptic vesicles.
@en
P2093
Alessandra Fratangeli
Anna Linetti
Elena Taverna
Maria Passafaro
Pamela Valnegri
Patrizia Rosa
P304
P356
10.1242/JCS.060681
P407
P577
2010-01-26T00:00:00Z